Prophylaxis for and treatment of deep venous thrombosis after stroke: The Post-Stroke Rehabilitation Outcomes Project (PSROP)

Topics in Stroke Rehabilitation

Volumn 12, Issue 4, 2005, Pages 1-10

  Zorowitz, Richard D ^a   Smout, Randall J ^b   Gassaway, Julie A ^b   Horn, Susan D ^b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTE FOR CLINICAL OUTCOMES RESEARCH   (United States)

^c INTERNATIONAL SEVERITY INFORMATION SYSTEMS INC   (United States)

Author keywords

Cerebrovascular accident; Cerebrovascular disorders; Rehabilitation; Venous thrombosis

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; DALTEPARIN; ENOXAPARIN; HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FEMORAL VEIN; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; STROKE; TREATMENT INDICATION; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBROVASCULAR ACCIDENT; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REGISTRIES; REHABILITATION CENTERS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOSIS;

EID: 31144458550     PISSN: 10749357     EISSN: None     Source Type: Journal    
DOI: 10.1310/9DQM-JTGL-WHAA-XYBW     Document Type: Article

References (33)

1. American Heart Association. Heart Disease and Stroke Statistics - 2005 Update. Dallas, TX: American Heart Association; 2005.
2. Duncan PW, Horner RD, Reker DM, et al. Adherence to post acute rehabilitation guidelines is associated with functional recovery. Stroke. 2002;33:167-178.
3. Buchanan JL, Rumpel JD, Hoenig H. Charges for outpatient rehabilitation: growth and differences in provider types. Arch Phys Med Rehabil. 1996;77:320-328.
4. DeJong G, Horn SD, Conroy B, Nichols D, Healton E. Opening the black box of post-stroke rehabilitation: stroke rehabilitation patients, processes, and outcomes. Arch Phys Med Rehabil. In press.
5. DeJong G. The Rise and Fall of American Post-acute Care. Washington, DC: NRH Press; 2003.
6. van der Worp HB, Kappelle LJ. Complications of acute ischaemic stroke. Cerebrovasc Dis. 1998;8:124-132.
7. Davenport RJ, Dennis MS, Wellwood I, Warlow CP. Complications following acute stroke. Stroke. 1996;27:415-420.
8. Kelly J, Rudd A, Lewis R, Hunt BJ. Venous thromboembolism after acute stroke. Stroke. 2001;32:262-267.
9. Joint Commission on Accreditation of Healthcare Organizations. Stroke disease-specific performance measures. Available at: http://www.jcaho.org/dscc/ psc/f_section4_oct04.pdf. Accessed August 2, 2005.
10. Büller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):401S-428S.
11. Davis SM, Donnan GA. Effective prophylaxis for deep venous thrombosis after stroke: both low-dose anticoagulation and stockings for most cases. Stroke. 2005;35:2910.
12. Adams HP. Effective prophylaxis for deep venous thrombosis after stroke: low-dose anticoagulation rather than stockings alone. For. Stroke. 2005;35:2911-2912.
13. Dennis MS. Effective prophylaxis for deep venous thrombosis after stroke: low-dose anticoagulation rather than stockings alone. Against. Stroke. 2005;35:2912-2913.
14. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):483S-512S.
15. Bromfield EB, Reding MB. Relative risk of deep venous thrombosis or pulmonary embolism post-stroke based upon ambulatory status. J Neurol Rehabil. 1988;2(2):51-56.
16. Gassaway J, Horn SD, DeJong G, Smout R, Clark C, James R. Applying the CPI approach to stroke rehabilitation: methods and baseline results. Arch Phys Med Rehabil. In press.
17. DeJong G, Horn SD, Gassaway JA, Slavin MD, Dijkers MP. Toward a taxonomy of rehabilitation interventions: using an inductive approach to examine the "black box" of rehabilitation. Arch Phys Med Rehabil. 2004;85(4):678-686.
18. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Fiscal Year 2005. Federal Register. 2004;69(146):45721-45775.
19. Stineman MG, Maislin G, Fiedler R, Granger CV. Functional task benchmarks for stroke rehabilitation. Arch Phys Med Rehabil. 1998;79(5):497-504.
20. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235-246.
21. Sandercock PA, van den Belt AG, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of the completed randomised trials. J Neurol Neurosurg Psychiatr. 1993;56:17-25.
22. International Stroke Trial Collaborative Group. The International Stroke Trial (1ST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349:1569-1581.
23. Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke: a meta-analysis of randomized controlled trials. Stroke. 2000;31:1770-1778.
24. Counsell C, Sandercock P. Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischemic stroke (Cochrane review). Stroke. 2002;33:1925-1926.
25. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Int Med. 2000;160:809-815.
26. Heit JA, O'Fallon WM, Petterson TM, Lohse CM, Silverstein MD, Mohr DN, Melton, LJ. Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study. Arch Int Med. 2002;162:1245-1248.
27. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 suppl):338S-400S.
28. Adams HP, Brott TG, Crowell RM, et al. Guidelines for the management of patients with acute ischemic stroke: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Circulation. 2002;90:1588-1601.
29. Coull BM, Williams LS, Goldstein LB, et al. Anticoagulants and antiplatelet agents in acute ischemic stroke: report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a division of the American Heart Association). Stroke. 2002;33:1934-1942.
30. Mazzone C, Chiodo Grandi F, Sandercock P, Miccio M, Salvi R. Physical methods for preventing deep vein thrombosis in stroke. In: The Cochrane Database of Systematic Reviews, Issue 3. Chichester, UK: John Wiley & Sons, Ltd.; 2005.
31. Kelly J, Rudd A, Lewis RR, Parmar K, Moody A, Hunt BJ. The relationship between acute ischaemic stroke and plasma D-dimer levels in patients developing neither venous thromboembolism nor major intercurrent illness. Blood Coag Fibrinol. 2003;14(7):639-645.
32. Horn SD, ed. Clinical Practice Improvement Methodology: Implementation and Evaluation. New York, NY: Faulkner & Gray; 1997.
33. Roth EJ, Lovell L, Harvey RL, Heinemann AW, Semik P, Diaz S. Incidence of and risk factors for medical complications during stroke rehabilitation. Stroke. 2001;32:523-529.